✦ LIBER ✦

Activity of Epothilone B Analogues Ixabepilone and Patupilone in Hormone-Refractory Prostate Cancer

✍ Scribed by Lee, David; Sartor, Oliver; Jain, Vinay K.

Book ID: 118627021
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 109 KB
Volume: 3
Category: Article
ISSN: 1540-0352
DOI: 10.1016/s1540-0352(11)70066-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Epothilone B (Patupilone) in Refr

Use of Epothilone B (Patupilone) in Refractory Lymphoma and Advanced Solid Tumors in Dogs

✍ Meier, V.; Geigy, C.; Grosse, N.; McSheehy, P.; Rohrer Bley, C. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Activity of second-line chemotherapy in

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone

✍ Jonathan E. Rosenberg; Vivian K. Weinberg; W. Kevin Kelly; Dror Michaelson; Maha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Abstract ## BACKGROUND. This randomized, noncomparative, multicenter, clinical trial evaluated ixabepilone or mitoxantrone/prednisone (MP) as second‐line chemotherapy for taxane‐refractory, hormone‐refractory, prostate cancer (HRPC). ## METHODS. Patients with HRPC that progressed during or wi

Clinical activity of the novel epothilon

Clinical activity of the novel epothilone B analog, ixabepilone, in triple negative breast cancer (BC) patients

✍ X. Pivot; A. Llombart-Cussac; M. Martin; M. Verrill; R. Peck; R.E. Conte 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

A retrospective evaluation of second-lin

A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma : Second-line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy

✍ Jonathan E. Rosenberg; Matthew D. Galsky; Nicholas C. Rohs; Vivian K. Weinberg; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

B-DIM Inhibits Androgen Receptor Activat

B-DIM Inhibits Androgen Receptor Activation and Potentiates Radiation Effect in Hormone Refractory Prostate Cancer

✍ Singh-Gupta, V.; Banerjee, S.; Sarkar, F.H.; Runyan, L.; Yunker, C.K.; Rakowski, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase I–II study of the somatostatin ana

Phase I–II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer

✍ C. Maulard, P. Richaud, J. P. Droz, D. Jessueld… 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 402 KB